Page last updated: 2024-10-30

losartan and Lymphoma, Large B-Cell, Diffuse

losartan has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Lymphoma, Large B-Cell, Diffuse: Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshimura, J1
Kato, S1
Tamaki, K1
Kohno, K1
Kaneyuki, U1
Maeda, M1
Saikusa-Itoh, Y1
Hayashida, A1
Iida, S1
Suefuji, H1
Okuda, S1

Other Studies

1 other study available for losartan and Lymphoma, Large B-Cell, Diffuse

ArticleYear
Mesangiolytic glomerulopathy after radiotherapy and chemotherapy of gastric lymphoma.
    Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:22

    Topics: Angiotensin II Type 1 Receptor Blockers; Antineoplastic Combined Chemotherapy Protocols; Combined Mo

2007